<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TP53 variants &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tp53-variants/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 15:52:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>TP53 variants &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Bayesian Method Enhances TP53 Variant Classification for Li-Fraumeni</title>
		<link>https://bioengineer.org/bayesian-method-enhances-tp53-variant-classification-for-li-fraumeni/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 15:51:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[en uygun 5 etiket şunlardır: **Bayesian methodology]]></category>
		<category><![CDATA[Genetic classification]]></category>
		<category><![CDATA[genetik danışmanlık iyileştirme** **Açıklama:** 1. **Bayesian varyant sınıflandırması:** Makalenin temel yeniliği ve]]></category>
		<category><![CDATA[Hereditary cancer** **Açıklama:** 1. **Bayesian methodology:** Makalenin ana yeniliği ve temel yaklaşımı Bayes metodolojis]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Bayesian varyant sınıflandırması]]></category>
		<category><![CDATA[kalıtsal kanser riski]]></category>
		<category><![CDATA[Li-Fraumeni sendromu]]></category>
		<category><![CDATA[Li-Fraumeni Syndrome]]></category>
		<category><![CDATA[Makalenin içeriği ve vurgulanan anahtar kavramlar dikkate alındığında]]></category>
		<category><![CDATA[TP53 gen mutasyonları]]></category>
		<category><![CDATA[TP53 variants]]></category>
		<guid isPermaLink="false">https://bioengineer.org/bayesian-method-enhances-tp53-variant-classification-for-li-fraumeni/</guid>

					<description><![CDATA[In a groundbreaking development, researchers have unveiled a novel and robust methodology for gene-specific variant classification that could significantly enhance clinical outcomes for patients with Li-Fraumeni syndrome, a hereditary cancer predisposition condition primarily associated with mutations in the TP53 gene. This updated approach is rooted in Bayesian methodology and aims to refine how genetic variants [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319014</post-id>	</item>
	</channel>
</rss>
